{"id":"W4286696947","doi":"10.1111/apt.17153","title":"Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Cilag; ZonMw; Celltrion; Gilead Sciences; GlaxoSmithKline; Achmea; Pfizer; Norgine; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Discontinuation; Ulcerative colitis; Adverse effect; Internal medicine; Inflammatory bowel disease; Gastroenterology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021605,0.0002280333,0.0003234735,0.0001975655,0.0006562033,0.0008785492,0.0003896178,0.0006533961,0.001390038],"category_scores_gemma":[0.007562003,0.0001917548,0.0004569577,0.0002790257,0.0003935637,0.0004393585,0.0005743095,0.0007629615,0.0002253194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00087931,"about_ca_system_score_gemma":0.0004692768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001636531,"about_ca_topic_score_gemma":0.00170779,"domain_scores_codex":[0.9986752,0.0006026417,0.0001212647,0.000231175,0.0001807524,0.0001890109],"domain_scores_gemma":[0.9962444,0.001389833,0.001180907,0.0002624011,0.000215368,0.0007071133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00562556,0.003783304,0.9000279,0.0001628175,0.0002826665,0.003714233,0.003021965,0.0007064318,0.002319585,0.0001210861,0.001567796,0.07866672],"study_design_scores_gemma":[0.002352548,0.02893689,0.9363981,0.0001743713,0.0003792797,0.01324568,0.004035762,0.003173746,0.001726423,0.0001945247,0.009287927,0.00009463666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992284,0.0002289807,0.00008000331,0.00007942918,0.000007787308,0.00001894755,0.00004066591,0.000003328534,0.0003125807],"genre_scores_gemma":[0.9993901,0.0001578598,0.0001140701,0.0001446974,0.00001817568,0.00001844989,0.00008453965,0.00000214353,0.00006988659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002021605,"threshold_uncertainty_score":0.0106914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01577564524183901,"score_gpt":0.2954949382348914,"score_spread":0.2797192929930524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}